Skip to main content
Top

Discover Oncology

Issue 2/2020

Content (6 Articles)

Breast Cancer Original Paper

Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer

Amy M. Fowler, Kelley Salem, Michael DeGrave, Irene M. Ong, Shane Rassman, Ginny L. Powers, Manoj Kumar, Ciara J. Michel, Aparna M. Mahajan

Breast Cancer Original Paper

Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells

Yu Pan, Xiuli Wang, Yanzhi Zhang, Juanjuan Qiao, Hironobu Sasano, Keely McNamara, Baoshan Zhao, Dongmei Zhang, Yuhua Fan, Lili Liu, Xueling Jia, Ming Liu, Sihang Song, Lin Wang

Glucocorticoid Original Paper

Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors

Julia R. Austin, Brenna J. Kirkpatrick, Rocío Rivera Rodríguez, Michael E. Johnson, Daniel D. Lantvit, Joanna E. Burdette

Melanoma Original Paper

Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer

Aida Orois, Celia Badenas, Jordi L. Reverter, Verónica López, Miriam Potrony, Mireia Mora, Irene Halperin, Josep Oriola

The Role of mPRδ and mPRε in Human Glioblastoma Cells: Expression, Hormonal Regulation, and Possible Clinical Outcome

Aylin Del Moral-Morales, Juan Carlos González-Orozco, José Moisés Capetillo-Velázquez, Ana Gabriela Piña-Medina, Ignacio Camacho-Arroyo

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.